Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MLTX
#2020
MoonLake Immunotherapeutics Class A Ordinary Shares
17.510
0
-0.68%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.68%
Monthly Change
+7.49%
6 month change
+83.16%
Year Change
+83.16%
Previous Close
17.630
0
Open
17.510
0
Bid
Ask
Low
17.510
0
High
17.510
0
Volume
76
Markets
US Stock Market
Healthcare
MLTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
63.06 M
63.28 M
63.47 M
63.5 M
63.7 M
71.73 M
—
Valuation ratios
Enterprise value
9.3 B
10.22 B
7.26 B
8.79 B
1.03 B
2.5 B
19.59 B
Price to earnings ratio
-40.02
-28.65
-16.99
-16.98
-2.16
-3.73
-39.86
Price to sales ratio
7 512.11
-80.7 K
-12.32 K
13.78 K
889.04
1 418.42
3 765.23
Price to cash flow ratio
-15.87
-29.2
-7.78
-14.57
-9.32
4.33
-27.34
Price to book ratio
1.45
7.62
1.32
1.75
0.3
2.79
6.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.07
-0.4
0.08
0.12
0.17
0.15
0.51
Return on equity %
-0.07
-0.42
0.1
0.15
0.24
0.21
0.7
Return on invested capital %
-774.68
-4 018
753.51
875.86
762.97
583.45
2 975.79
Gross margin %
100
100
100
100
100
100
400
Operating margin %
161.19 K
140.68 K
135.67 K
16.06 K
26.75 K
-80.51 K
97.97 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
132.32 K
114.32 K
114.13 K
14.61 K
26.12 K
-77.07 K
77.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
25.51
21.11
21.11
16.65
8.5
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
-0
0
0
0
-0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.14
0.16
0.18
0.17
0.65
Long term debt to total equity ratio
—
—
0.18
0.21
0.26
0.24
0.89
Per share metrics
Operating cash flow per share
-1.76
-2.94
0.6
0.86
0.7
0.91
3.08
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.85
7.13
7.59
6.72
6
6.11
26.43
Net current asset value per share
8.15
7.54
8.01
7.2
6.49
6.54
28.23
Tangible book value per share
7.77
7.11
6.44
5.59
4.56
4.72
21.32
Working capital per share
7.83
7.19
7.63
6.77
5.73
5.84
25.95
Book value per share
7.76
7.11
6.44
5.59
4.56
4.72
21.32
News
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
MoonLake stock surges on positive axSpA trial data
MoonLake stock surges 63% after InvestingPro Fair Value call
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
BTIG reiterates Buy rating on Moonlake Immunotherapeutics stock ahead of data
H.C. Wainwright reiterates Buy rating on Moonlake stock with $32 target
MoonLake stock surges after FDA grants Fast Track designation for PPP treatment
FDA grants fast track designation for sonelokimab in PPP
Goldman Sachs downgrades Moonlake Immunotherapeutics stock to Sell on HS approval concerns